Bridgepoint, one of the world’s leading quoted private asset growth investors, today announced that it has agreed to acquire a significant controlling stake in Safe Life, the global leader in the distribution of automated external defibrillators (AEDs), in a transaction that values the company at c. €500 million.
Headquartered in Stockholm, Safe Life operates across North America and Europe and is a market leader in a highly fragmented and fast-growing sector. The company equips communities and workplaces with lifesaving AEDs supported by ongoing services, including CPR training, maintenance and replacement parts such as pads and batteries to enable a fast and effective response in an emergency.
Bridgepoint will partner with Safe Life’s founders and existing institutional investors including Byggmästaren, Bonnier Capital and Swedbank Robur, all of whom are materially reinvesting alongside Bridgepoint.
Since its founding in 2019, the company has distributed over 500,000 AEDs globally and is set to deliver over €250m of sales in 2025.
Cardiac arrest remains one of the leading causes of death globally. This partnership will support Safe Life in its mission to expand access to defibrillators and help communities respond with confidence when it matters most. With Bridgepoint’s backing, the company will continue to raise awareness about the importance of AED access, ongoing maintenance, and training. It will do so through international expansion, the growth of its aftermarket and training capabilities and continued M&A, ultimately helping to save more lives in the markets it serves.
Growing public awareness and evolving health and safety regulation are driving demand, with the core AED market growing rapidly. Crucially, growth is no longer just about the supply of devices, there is increasing focus on ensuring they remain ready to use, through proper support and upkeep.
Jimmy Eriksson and Alexander Albedj, Co-Founders of Safe Life, said:
"Our mission has always been simple: to save lives by making defibrillators and training more accessible. In Bridgepoint, we’ve found a partner who not only believes in that mission but brings the expertise and scale to help us reach more communities around the world, and to support us to grow further, faster. Every second counts in an emergency, and this partnership will help ensure that time makes a difference.”
Chris Bley, Partner and Co-Head of the Nordics at Bridgepoint, added:
"We’re thrilled to be backing Safe Life’s next chapter. This is a classic Bridgepoint investment: a founder-led, mission-driven company operating in a large and growing market. Safe Life has built a standout platform, combining leadership in AED distribution with a comprehensive offer of ongoing services and maintenance, ensuring these life-saving devices are ready when they’re needed most. We see meaningful opportunities for expansion, both organically and through continued M&A, and are excited to support the team as they take the business to the next level."
Tomas Bergström, Safe Life Chair and Byggmästaren CEO, commented:
"It has been a privilege working with Jimmy and Alexander for the past five years. They are exceptional entrepreneurs and with Bridgepoint now on board they can accelerate further. As we remain a significant shareholder I look forward to the continued journey and will support in all the ways I can.”
Safe Life operates in one of Bridgepoint’s core focus areas: Medtech products that improve patient outcomes and offer strong growth potential across multiple markets. Bridgepoint has deep experience in this space, having backed companies such as Balt, a global specialist in neurovascular devices for stroke and aneurysm treatment; and Vivacy, a European leader in regenerative and aesthetic medicine injectables.
The partnership also builds on Bridgepoint’s strong track record of supporting Swedish-founded businesses to expand internationally. Previous investments include Diaverum, a global provider of life-sustaining dialysis care operating in 23 countries, and Vitamin Well, a health and wellness drinks company with distribution across 40 markets. Both were supported by Bridgepoint’s Stockholm team and scaled significantly under its ownership through international expansion and business development.
The transaction is subject to customary closing conditions including regulatory approval and is expected to complete in Q3 2025.
Bridgepoint was advised by Jefferies (M&A Advisor), Vinge (Legal Advisor), EY (Financial, Tax & Operational Due Diligence), Strategy& (Commercial), ERM (ESG) and Marsh (Insurance).
Safe Life was advised by Baker & McKenzie (Legal Advisor).